Cite
HARVARD Citation
Reynolds, A. et al. (2012). When is switching warranted among biologic therapies in rheumatoid arthritis?. Expert review of pharmacoeconomics & outcomes research. pp. 319-333. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Reynolds, A. et al. (2012). When is switching warranted among biologic therapies in rheumatoid arthritis?. Expert review of pharmacoeconomics & outcomes research. pp. 319-333. [Online].